ÃÛÌÇÖ±²¥

Skip to main content

August 9, 2022: Zebras No More – Studying Autism in a Time of Increasing Prevalence

NextGen Discovery Series | Stephen Sheinkopf, PhD

The NextGen Precision Health Discovery Series provides learning opportunities for UM System faculty and staff across disciplines, the statewide community and our other partners to learn about the scope of precision health research and identify potential collaborative opportunities. The series consists of monthly lectures geared toward a broad multidisciplinary audience so all can participate and appreciate the spectrum of precision health efforts. 

Information about the upcoming talk, including continuing education, is available below.

For questions about this event or any others in the Discovery Series, please reach out to Mary Christie at mchristie@health.missouri.edu

Zebras No More – Studying Autism in a Time of Increasing Prevalence

Speaker: Stephen Sheinkopf, PhD, Executive Director of the Thompson Center for Autism and Neurodevelopmental Disorders

Date: Tuesday, August 9, 2022, noon-1 p.m.

Description

Dr. Sheinkopf will discuss findings from ongoing studies of Autism Spectrum Disorders, studies that include early infancy through early adulthood. He will discuss the challenges posed - and opportunities presented - by the varied and heterogeneous clinical presentations in autism.

ÃÛÌÇÖ±²¥ the Speaker 

Stephen Sheinkopf is a Professor of Child Health at the University of ÃÛÌÇÖ±²¥ and serves as the Executive Director of the Thompson Center for Autism and Neurodevelopmental Disorders. Dr. Sheinkopf completed his doctoral training at the University of Miami in the lab of Peter Mundy, PhD. Following his time in Miami, he completed his clinical internship and postdoctoral fellowship in the Department of Psychiatry and Human Behavior at Brown University. His postdoctoral work was supported by an NIH-funded individual National Health Service Award (NRSA), training in the laboratory of Barry Lester, PhD. Dr. Sheinkopf stayed on at Brown University after fellowship, rising to the rank of Associate Professor of Psychiatry and Pediatrics and taking on major leadership roles, including directing the Rhode Island Consortium for Autism Research and Treatment and co-directing the Autism Initiative of the Hassenfeld Child Health Innovation Institute. Dr. Sheinkopf moved to the University of ÃÛÌÇÖ±²¥ in 2021, joining MU as the Executive Director of the Thompson Center.

 

Continuing Professional Education Credit

Nurses

Up to 1.0 contact hour will be awarded to all participants who view the live sessions in their entirety and complete the evaluation form.

University of ÃÛÌÇÖ±²¥ is approved as a provider of nursing continuing professional development by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Midwest Multistate Division Provider Number MO1022-6

Physicians

The , School of Medicine, University of ÃÛÌÇÖ±²¥ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

The Office of Continuing Education, School of Medicine, University of ÃÛÌÇÖ±²¥ designates this live educational activity for a maximum of AMA PRA Category 1 Credit(s)â„¢.  Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Financial Relationship Disclosure: Current ACCME (Accreditation Council for Continuing Medical Education) and Midwest Multistate Division, ANCC (American Nurses Credentialing Center’s Commission on Accreditation) rules state that participants in CE activities should be made aware of any relevant affiliation or financial interest in the previous 24 months that may affect the planning of an educational activity or a speaker’s presentation(s). Each planning committee member and speaker has been requested to complete a conflict of interest statement for the NextGen Precision Health Discovery Series.  No planning committee member or speaker has a relevant financial interest.

Reviewed 2024-09-30